Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa

HIV Medicine

Volumn 16, Issue 8, 2015, Pages 468-476

  Govender, N P ^a,b   Roy, M ^c   Mendes, J F ^b,d   Zulu, T G ^a   Chiller, T M ^c   Karstaedt, A S ^b,e  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Gauteng Health Department   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cryptococcal antigen; Cryptococcal meningitis; Evaluation; Screen and treat; South Africa

Indexed keywords

FLUCONAZOLE; ANTIFUNGAL AGENT; FUNGUS ANTIGEN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CRYPTOCOCCAL ANTIGENAEMIA; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; DISEASE COURSE; EVALUATION STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BLOOD; COMPLICATION; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; SOUTH AFRICA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; ANTIGENS, FUNGAL; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCUS NEOFORMANS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SOUTH AFRICA;

EID: 84938745237     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12245     Document Type: Article

References (31)

1. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis 2010; 10: 67.
2. Hakim JG, Gangaidzo IT, Heyderman RS etal. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 2000; 14: 1401-1407.
3. Bekondi C, Bernede C, Passone N etal. Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus. Int J Infect Dis 2006; 10: 387-395.
4. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908.
5. Lawn SD, Bekker LG, Myer L, Orrell C, Wood R. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 2005; 19: 2050-2052.
6. Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van RA. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: a prospective cohort study. J Int AIDS Soc 2009; 12: 38.
7. Gupta A, Nadkarni G, Yang WT etal. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS ONE 2011; 6: e28691.
8. World Health Organization. Rapid Advice - Diagnosis, Prevention and Management of Cryptococcal Disease in HIV-Infected Adults, Adolescents and Children. Geneva, World Health Organization, December 2011. Available at: www.who.int/hiv/pub/cryptococcal_disease2011/en/ (accessed 12 November 2014).
9. Parkes-Ratanshi R, Wakeham K, Levin J etal. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis 2011; 11: 933-941.
10. Jarvis JN, Lawn S, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenaemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009; 48: 856-862.
11. Jarvis JN, Lawn SD, Wood R, Harrison TS. Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action. Clin Infect Dis 2010; 51: 1463-1465.
12. Klausner JD, Govender N, Oladoyinbo S, Roy M, Chiller T. Preventing AIDS deaths: cryptococcal antigen screening and treatment. Lancet Infect Dis 2012; 12: 431-432.
13. Abimbola TO, Marston BJ. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr 2012; 60: e8-e14.
14. Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S. Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. PLoS ONE 2013; 8: e69288.
15. South African National AIDS Council. National Strategic Plan on HIV, STIs and TB, 2012-2016, Pretoria: South African National AIDS Council, 2012. Available at: http://www.sanac.org.za/index.php/resources/national-strategic-plan (accessed 12 November 2014).
16. Govender NP, Roy M, Oladoyinbo S etal. Phased Implementation of Screening for Cryptococcal Disease in South Africa. S Afr Med J 2012; 102: 914-917.
17. National Department of Health. National Antiretroviral Treatment Guidelines. Pretoria, National Department of Health, 2004: Available at: http://www.doh.gov.za/docs/facts/2004/intro.pdf (accessed 12 November 2014).
18. Govender NP, Patel J, van Wyk M, Chiller TM, Lockhart SR, for GERMS-SA. Trends in antifungal drug susceptibility of Cryptococcus neoformans obtained through population-based surveillance, South Africa, 2002-2003 and 2007-2008. Antimicrob Agents Chemother 2011; 55: 2606-2611.
19. Mugglin C, Estill J, Wandeler G etal. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 2012; 17: 1509-1520.
20. Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2012; 15: 17383.
21. McMullan BJ, Halliday C, Sorrell TC etal. Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS ONE 2012; 7: e49541.
22. Jarvis JN, Percival A, Bauman S etal. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis 2011; 53: 1019-1023.
23. Govender NP, Zulu TG, Lawrie D etal. Detection of cryptococcal antigenaemia from whole blood specimens for rapid diagnosis of cryptococcal disease among HIV-infected adults in South Africa (abstract TUPE263). International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. Kuala Lumpur, Malaysia, July 2013.
24. Meya DB, Manabe YC, Castelnuovo B etal. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin Infect Dis 2010; 51: 448-455.
25. Kambugu A, Meya DB, Rhein J etal. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis 2008; 46: 1694-1701.
26. Jarvis JN, Govender N, Chiller T etal. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic) 2012; 11: 374-379.
27. Rajasingham R, Meya DB, Boulware DR. Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care. J Acquir Immune Defic Syndr 2012; 59: e85-e91.
28. Oyella J, Meya D, Bajunirwe F, Kamya MR. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study. J Int AIDS Soc 2012; 15: 15.
29. Karstaedt AS. Profile of cause of death assigned to adults on antiretroviral therapy in Soweto. S Afr Med J 2012; 102: 680-682.
30. Micol R, Lortholary O, Sar B etal. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007; 45: 555-559.
31. Plazy M, Dray-Spira R, Orne-Gliemann J, Dabis F, Newell ML. Continuum in HIV care from entry to ART initiation in rural KwaZulu-Natal, South Africa. Trop Med Int Health 2014; 19: 680-689.